2009 H1N1 Pandemic and Seasonal Influenza in SCI/D: Infection Control Strategies
NCT01270685 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2015-06-26
Summary
The purpose of this study is to evaluate specific approaches used to prevent/reduce influenza transmission in the SCI/D System of Care in response to the 2009 H1N1 pandemic, including assessing infection control strategies used by SCI staff and guidance provided by local infection control units. Due to the rapid spread of and uncertainties about the H1N1 virus, we will evaluate patient's beliefs, behaviors, and information seeking strategies (e.g., social media). These findings will lend to the understanding of ways to handle emergent issues, such as the H1N1 pandemic, in special populations.
Conditions
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Principal Investigators
-
Sherri L. LaVela, MPH MBA PhD · Edward Hines Jr. VA Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-07-31
- Primary Completion
- 2011-04-30
- Completion
- 2011-08-31
Countries
- United States
Study Locations
More Related Trials
-
Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)
NCT01910519 ·Status: COMPLETED ·Phase: PHASE2
-
Inpatient Influenza Surveillance
NCT00419861 ·Status: COMPLETED
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
Prospective Study of AI H5N1 in China
NCT00428493 ·Status: COMPLETED
-
A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents
NCT02352389 ·Status: COMPLETED
-
Evaluating Modes of Influenza Transmission 2b Baseline SAR
NCT07342556 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intervention Study of Face Mask and Hand Sanitizer to Reduce Influenza Transmission
NCT00490633 ·Status: COMPLETED ·Phase: NA
-
Household Influenza Transmission Study
NCT01251679 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
NCT00800605 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
NCT02385123 ·Status: TERMINATED ·Phase: PHASE4
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
Household Transmission of Zoonotic Influenza Viruses in a Cohort of Egyptian Poultry Growers
NCT02459171 ·Status: COMPLETED
-
Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7
NCT00922259 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)
NCT00566345 ·Status: COMPLETED ·Phase: PHASE3
-
H5N1 Priming and Boosting Strategies
NCT00703053 ·Status: COMPLETED ·Phase: PHASE2
-
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)
NCT01551810 ·Status: COMPLETED ·Phase: PHASE3
-
Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.
NCT00522067 ·Status: COMPLETED ·Phase: PHASE2
-
Influenza in People With Normal and Weakened Immune Systems
NCT00533182 ·Status: COMPLETED
-
Surveillance of Influenza Virus Shedding and Immunologic Response in Immunocompromised Children and Young Adults
NCT00998803 ·Status: COMPLETED
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects
NCT00518726 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Modes of Influenza Transmission Between Humans
NCT01150149 ·Status: WITHDRAWN ·Phase: NA
-
The Effectiveness of Influenza Vaccine Among Health Care Workers in a Hospital Setting.
NCT00265161 ·Status: COMPLETED
-
China Case Control Avian Influenza
NCT00428753 ·Status: COMPLETED
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects
NCT00329927 ·Status: COMPLETED ·Phase: PHASE2
-
High Dose Influenza Vaccine in Nursing Home - Pilot Study
NCT01720277 ·Status: COMPLETED ·Phase: PHASE4